Heska Corp (NASDAQ:HSKA) released its quarterly earnings data on Thursday. The medical research company reported $0.40 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.03, Briefing.com reports. The company had revenue of $31.40 million during the quarter, compared to analyst estimates of $36.10 million. Heska Corp had a net margin of 9.81% and a return on equity of 12.52%. Heska Corp’s revenue for the quarter was down 6.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.45 EPS.

Shares of Heska Corp (HSKA) traded down $10.29 during trading hours on Friday, hitting $86.74. 145,426 shares of the company were exchanged, compared to its average volume of 67,052. The company has a market capitalization of $590.80 million, a PE ratio of 42.81, a P/E/G ratio of 2.39 and a beta of 0.83. The company has a current ratio of 2.30, a quick ratio of 1.12 and a debt-to-equity ratio of 0.10.

HSKA has been the subject of a number of recent research reports. Aegis boosted their price target on shares of Heska Corp from $114.50 to $129.50 and gave the company a “buy” rating in a research note on Tuesday, August 1st. B. Riley decreased their price target on shares of Heska Corp from $96.50 to $93.00 and set a “neutral” rating for the company in a research note on Friday. BidaskClub lowered shares of Heska Corp from a “buy” rating to a “hold” rating in a research note on Sunday, July 16th. Zacks Investment Research upgraded shares of Heska Corp from a “hold” rating to a “buy” rating and set a $109.00 price target for the company in a research note on Friday, August 4th. Finally, Benchmark Co. restated a “buy” rating and set a $120.00 price target (up previously from $106.00) on shares of Heska Corp in a research note on Wednesday, August 9th. Five equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $106.25.

WARNING: This piece was posted by American Banking News and is the property of of American Banking News. If you are viewing this piece on another site, it was copied illegally and republished in violation of U.S. & international copyright law. The correct version of this piece can be viewed at https://www.americanbankingnews.com/2017/11/04/heska-corp-hska-releases-quarterly-earnings-results-beats-expectations-by-0-03-eps.html.

In other Heska Corp news, EVP Nancy Wisnewski sold 825 shares of Heska Corp stock in a transaction on Thursday, August 31st. The shares were sold at an average price of $102.21, for a total transaction of $84,323.25. Following the transaction, the executive vice president now directly owns 38,114 shares of the company’s stock, valued at approximately $3,895,631.94. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO John Mcmahon sold 2,608 shares of Heska Corp stock in a transaction on Wednesday, August 30th. The stock was sold at an average price of $101.17, for a total transaction of $263,851.36. Following the transaction, the chief financial officer now directly owns 193 shares in the company, valued at $19,525.81. The disclosure for this sale can be found here. Insiders own 14.70% of the company’s stock.

Heska Corp Company Profile

Heska Corporation sells veterinary diagnostic and specialty products. The Company operates through two segments: Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products (OVP). The CCA segment includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings, such as in-clinic diagnostic tests and heartworm preventive products.

Earnings History for Heska Corp (NASDAQ:HSKA)

Receive News & Ratings for Heska Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heska Corp and related companies with MarketBeat.com's FREE daily email newsletter.